ebook Munafa Stock Market Course + Intraday & FNO calls  

       

RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared USA

Dr. Reddy's Laboratories Ltd Complete list of announcements declared & dividend announcements by Dr. Reddy's Laboratories Ltd RDY

Dr. Reddy's Laboratories Ltd RDY listed on USA and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Dr. Reddy's Laboratories Ltd RDY

Potential US tariff a significant 'unknown' for business, says Dr Reddy's Lab CEO
Dr. Reddy's Laboratories is closely monitoring a potential US tariff on the pharma sector, viewing it as both a risk and opportunity. The company plans a significant expansion with the generic version of semaglutide across 87 countries by 2026, alongside d
Announcement as on 23 July 2025

Dr Reddy's plans to launch generic of Novo's weight-loss drug next year, CEO says
Dr. Reddy's Laboratories intends to introduce a more affordable generic version of Novo Nordisk's popular weight-loss medication, Wegovy, in 87 countries starting next year. This strategic move aims to capitalize on the burgeoning global obesity drug marke
Announcement as on 23 July 2025

Dr Reddy’s Q1 Results Preview: PAT may grow up to 15% YoY, revenue to surge up to 19%
Dr Reddy’s Q1FY26 earnings are expected to show steady revenue growth and resilient domestic demand, with mixed profit estimates ranging from a 2% decline to 15% growth. US performance may be tempered by lower Revlimid sales, while domestic strength cont
Announcement as on 22 July 2025

Dr Reddy's gets seven observations from USFDA for Andhra plant
Dr Reddy's Laboratories faces scrutiny. The USFDA issued a Form 483 after inspecting their Srikakulam facility. The inspection, which occurred in July 2025, revealed seven observations. These observations relate to potential violations of the Food, Drug an
Announcement as on 20 July 2025

Dr Reddys Share Price Live Updates: Dr. Reddy's Laboratories shows impressive returns

Announcement as on 14 July 2025

Announcements by Dr. Reddy's Laboratories Ltd first page | Next page | Prev page |

RDY Dr. Reddy's Laboratories Ltd current price & indicator signals

Moving Averages for Dr. Reddy's Laboratories Ltd

  • 5Day Average: 13.57
  • 12Day Average: 13.34
  • 20Day Average: 13.46
  • 50Day Average: 13.47
  • 100Day Average: 13.71
  • 150Day Average: 13.81
  • 200Day Average: 13.93

RDY Indicators & signals

Indicator MACD (12,26,9)

13.43, 13.43, -0.05
Indicator MACD is in positive zone

Indicator ADX (14)

5.26, 25.71, 28.57
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 54
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of RDY Dr. Reddy's Laboratories Ltd are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
21 Thu May 2026 13.55 13.42 to 13.61 -0.59% 0.55 times
20 Wed May 2026 13.63 13.35 to 13.64 1.34% 0.54 times
19 Tue May 2026 13.45 13.45 to 13.60 -1.1% 0.65 times
18 Mon May 2026 13.60 13.54 to 13.74 -0.07% 0.68 times
15 Fri May 2026 13.61 13.58 to 13.90 0.89% 0.67 times
14 Thu May 2026 13.49 13.28 to 13.65 3.85% 0.98 times
13 Wed May 2026 12.99 12.74 to 13.00 4.25% 1.96 times
12 Tue May 2026 12.46 12.19 to 12.74 -5.18% 1.85 times
11 Mon May 2026 13.14 13.11 to 13.29 -0.68% 1 times
08 Fri May 2026 13.23 13.22 to 13.56 -1.49% 0.75 times
07 Thu May 2026 13.43 13.43 to 13.65 -0.22% 0.93 times
06 Wed May 2026 13.46 13.40 to 13.72 0% 1.29 times

Videos related to: RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared USA

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared USA

 

Back to top